Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
1,045.00
-10.00 (-0.95%)
Oct 19, 2026, 2:47 PM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 119.28 million as of October 19, 2026. It is the 32,123rd most valuable company in the world and the 369th biggest in Israel. Its market cap has decreased by 12.41% in one year.
Market Cap
119.28M
Enterprise Value
234.52M
Revenue
304.04M
Global Rank
Country Rank
#369 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 119.28M, an increase of 10.53%. That is a compound annual growth rate of 0.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 119.28M | -4.48% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.72B |
| Amal Holdings A.D. | 2.21B |
| Rafa Laboratories | 1.79B |
| BrainsWay | 1.47B |
| Bonus BioGroup | 205.59M |
| InterCure | 177.92M |
| Golden House | 156.56M |
| Epitomee Medical | 105.53M |